ABSTRACT
Improvements in technology leading to increased and early detection of small tumors have resulted in complex decision algorithms for treating various genitourinary malignancies. This is particularly true when imaging can be combined with some type of therapeutic intervention. In the management of malignancies there is a growing interest in focal therapies or simple monitoring of disease through active surveillance. In both cases there is a critical need for accurate imaging of the organ in question.
